Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Birgit Schif"'
Autor:
Maria Rita Gaiser, Alexander Skorokhod, Diana Gransheier, Benjamin Weide, Winfried Koch, Birgit Schif, Alexander Enk, Claus Garbe, Jürgen Bauer
Publikováno v:
PLoS ONE, Vol 12, Iss 11, p e0188602 (2017)
The incidence of melanoma, particularly in older patients, has steadily increased over the past few decades. Activating mutations of BRAF, the majority occurring in BRAFV600, are frequently detected in melanoma; however, the prognostic significance r
Externí odkaz:
https://doaj.org/article/86d811d7560949c0b63ed58ae40e23ba
Autor:
Birgit Schif, David B. Liesenfeld, Winfried Koch, Peter Schirmacher, Claus Garbe, Arndt Hartmann, William Sterlacci
Publikováno v:
Virchows Archiv : an international journal of pathology. 474(1)
Quality control of BRAF mutation testing methods used in routine practice is crucial for optimal treatment selection. In this prospective study, we assessed the impact of patient/sample characteristics on BRAF mutation testing results in patients wit
SOCS1 Mutation Subtypes Predict Divergent Outcomes in Diffuse Large B-Cell Lymphoma (DLBCL) Patients
Autor:
Birgit Schif, Peter Möller, Ingo Melzner, Rainer Spang, Markus Kreuz, Lorenz Trümper, Olga Ritz, Markus Loeffler, Jochen K. Lennerz, Christian W. Kohler, Stefan Bentink
Publikováno v:
Oncotarget
// Birgit Schif 1,* , Jochen K. Lennerz 1,* , Christian W. Kohler 2 , Stefan Bentink 2 , Markus Kreuz 3 , Ingo Melzner 1 , Olga Ritz 1 , Lorenz Trumper 4 , Markus Loeffler 3 , Rainer Spang 2 , and Peter Moller 1 1 Institute of Pathology, University o
Autor:
Benjamin Weide, Birgit Schif, Claus Garbe, Jürgen Bauer, Winfried Koch, Maria Rita Gaiser, Alexander Enk, Alexander Skorokhod, Diana Gransheier
Publikováno v:
PLoS ONE, Vol 12, Iss 11, p e0188602 (2017)
PLoS ONE
PLoS ONE
Background The incidence of melanoma, particularly in older patients, has steadily increased over the past few decades. Activating mutations of BRAF, the majority occurring in BRAFV600, are frequently detected in melanoma; however, the prognostic sig
Autor:
Claus Garbe, Arndt Hartmann, William Sterlacci, Birgit Schif, Winfried Koch, Peter Schirmacher
Publikováno v:
Journal of Clinical Oncology. 34:e23142-e23142
e23142Background: BRAFV600 testing is mandatory before initiating targeted therapy in patients (pts) with advanced stage malignant melanoma, but testing quality is still an issue and comparability ...
Autor:
Gaiser, Maria Rita1,2 maria.gaiser@umm.de, Skorokhod, Alexander1, Gransheier, Diana3, Weide, Benjamin3, Koch, Winfried4, Schif, Birgit5, Enk, Alexander1, Garbe, Claus3, Bauer, Jürgen3
Publikováno v:
PLoS ONE. 11/27/2017, Vol. 12 Issue 11, p1-13. 13p.
Autor:
Hartmann, Arndt, Schirmacher, Peter, Sterlacci, William, Koch, Winfried, Liesenfeld, David B., Schif, Birgit, Garbe, Claus
Publikováno v:
Virchows Archiv: European Journal of Pathology; Jan2019, Vol. 474 Issue 1, p71-78, 8p
Autor:
Lennerz, Jochen K., Weissinger, Stephanie E., Gerstenmaier, Uwe, Marienfeld, Ralf, Möller, Peter
Publikováno v:
British Journal of Haematology; Oct2017, Vol. 179 Issue 1, p158-160, 3p, 1 Graph